CDT Equity Inc. (CDT)
NASDAQ: CDT · Real-Time Price · USD
0.5345
-0.0485 (-8.32%)
Jun 30, 2026, 12:02 PM EDT - Market open
CDT Equity Employees
CDT Equity had 4 employees as of December 31, 2025. The number of employees decreased by 2 or -33.33% compared to the previous year.
Employees
4
Change (1Y)
-2
Growth (1Y)
-33.33%
Revenue / Employee
n/a
Profits / Employee
-$9,806,000
Market Cap
2.60M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 4 | -2 | -33.33% |
| Dec 31, 2024 | 6 | -1 | -14.29% |
| Dec 31, 2023 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Calidi Biotherapeutics | 29 |
| Virax Biolabs Group | 19 |
| VivoSim Labs | 14 |
| Azitra | 13 |
| Creative Medical Technology Holdings | 4 |
| GRI Bio | 4 |
| Oragenics | 3 |
| SciSparc | 3 |
CDT News
- 4 days ago - CDT Highlights Sarborg's Application of Quantum Computing to Solid-Form Development - GlobeNewsWire
- 12 days ago - CDT Equity notes investment into Sarborg, expansion into quantum computing - TheFly
- 12 days ago - CDT Notes Strategic Investment into Sarborg and Expansion into Quantum Computing - GlobeNewsWire
- 14 days ago - CDT Equity Announces Debt Update and New Loan Facility - GlobeNewsWire
- 4 weeks ago - CDT Equity receives Nasdaq notice for delayed quarterly report - TheFly
- 4 weeks ago - CDT Equity Inc. Announces Receipt of Nasdaq Deficiency Letter - GlobeNewsWire
- 4 weeks ago - CDT Equity granted Canadian patent for AZD5904 in male infertility - TheFly
- 4 weeks ago - CDT Announces Canadian Patent for AZD5904 in Male Infertility - GlobeNewsWire